Zhenglun Liang - Concepedia

Author

Zhenglun Liang

National Institutes for Food and Drug Control ORCID

Also Known As

Liang Zhenglun, Liang, Zhenglun, Z Liang, Z. Liang, Z.-L. Liang, Z.L. Liang, Zenghua Liang, Zheng-Lun Liang, Zheng-lun LIANG, Zheng-lun Liang

211

Publications

Citations

H-Index

Concepts

All Affiliations

National Institutes for Food and Drug Control Jiangsu Provincial Center for Disease Control and Prevention Chinese Academy of Medical Sciences & Peking Union Medical College Xiamen University Centers for Disease Control and Prevention

About

Zhenglun Liang is an author at National Institutes for Food and Drug Control specializing in immunology, medicine, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	31	1.8K
2	Allergy	4	4	256
3	Engineering	1	1	10
4	Biology	1	1	28
5	Biomedical Engineering	1	1	10

Zhenglun Liang

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China Fengcai Zhu, Wenbo Xu, Jielai Xia, New England Journal of Medicine	2014	458
An Inactivated Enterovirus 71 Vaccine in Healthy Children Rongcheng Li, Longding Liu, Zhaojun Mo, New England Journal of Medicine	2014	395
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Fengcai Zhu, Fanyue Meng, Jingxin Li, The Lancet VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirology	2013	382
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates Qian He, Qunying Mao, Chaoqiang An, Emerging Microbes & Infections VaccinationVaccine DevelopmentMedicineVaccine SurveillanceVaccine Target	2021	164
Molecular Determinants of Enterovirus 71 Viral Entry Chen Pan, Zilin Song, Yonghe Qi, Journal of Biological Chemistry Molecular VirologyPathogenesisViral PathogenesisImmunologyMolecular Determinants	2012	129
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine Qian He, Chaoqiang An, Qunying Mao, Emerging Microbes & Infections Vaccine ResearchImmunologyImmunodominanceInactivated Sars-cov-2 VaccineImmunotherapy	2021	102
Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity Jun Zhang, X.-F. Zhang, Cheng Zhou, Clinical Microbiology and Infection VaccinationVaccine DevelopmentViral HepatitisVaccine TargetImmunology	2013	93
Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial Yanping Li, Zhenglun Liang, Qiang Gao, Vaccine VaccinationVaccine SafetyVaccine DevelopmentVaccine TargetImmunology	2012	93
A Neonatal Mouse Model of Coxsackievirus A16 for Vaccine Evaluation Qunying Mao, Yiping Wang, Rong Gao, Journal of Virology	2012	93
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial Fengcai Zhu, Zhenglun Liang, Xiuling Li, The Lancet VaccinationVaccine SafetyPlacebo-controlled Phase 2Vaccine DevelopmentImmunology	2013	87

Page 1